Roots Analysis has announced the addition of “Single use Bioreactors Market, 2023-2035” report to its list of offerings.
Single use bioreactors offer various advantages over conventional technologies, such as ease of installation, increased efficiency of the biomanufacturing process, operational flexibility, reduced risk of cross contamination, less energy and water consumption. In pursuit of both time and cost savings, as well as to mitigate the challenges associated with the conventional stainless-steel bioreactors, manufacturers prefer to use single use bioreactors, in order to ensure the development of high-quality biologics.
To order this 350+ page report, which features 120+ figures and 160+ tables, please visit this link
This segment of the industry is dominated by the presence of players (38%) established before 2001, followed by companies established post-2015 (18%). It is worth mentioning that 16% of the players established post-2015 are small companies (2-50 employees).
Majority of the single use bioreactors (57%) are stirred tank bioreactors using agitation mechanism. Further, most of the single use bioreactors are suitable for processing mammalian cell culture and 90% of the bioreactors are capable of culturing more than one type of cell.
Of these, close to 30% deals were inked in the last three years. Majority of the instances captured in the report were supply agreements (27%). In addition, more than 55% of deals have been inked by players to supply stirred tank single use bioreactors for biomanufacturing.
The current market is driven by stirred tank bioreactors, which hold around 70% share of the overall single use bioreactors market; this trend is unlikely to change in the foreseen future as well. Further, in terms of scale of operation, bioreactors designed for commercial scale operations capture major share (55%) of the market in 2035.
In terms of type of biologics synthesized, vaccines and monoclonal antibodies are expected to capture around 50% of the total single use bioreactors market in 2035. Further, close to 65% of the single use bioreactors market is captured by biopharmaceutical / pharmaceutical industries.
To request a sample copy / brochure of this report, please visit this link
The financial opportunity within the single use bioreactors market has been analyzed across the following segments:
The report features inputs from eminent industry stakeholders, according to whom, the increase in the demand for cell and gene therapies is driving the growth of the single use bioreactors market. The report includes detailed transcripts of discussions held with the following experts:
The research also includes detailed profiles of key players (listed below) engaged in offering single use bioreactors; each profile features a brief overview of the company, its financial information (if available), details on product portfolio, recent developments and an informed future outlook.
For additional details, please visit https://www.rootsanalysis.com/reports/single-use-bioreactors-market.html or email sales@rootsanalysis.com
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.chaudhary@rootsanalysis.com
MEDIA CITATIONS
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry
SUBSCRIBE TO INDUSTRY UPDATES
.png)
